32 Results for "

CRT

" in MedChemExpress (MCE) Product Catalog:
Products (32)

32 Results for "CRT" in MCE Product Catalog:

20
20 Publications Verification
Cat. No.: HY-16665
CAS No.: 677331-12-3
Target:  

Wnt

Research Areas:  

Cancer

iCRT 14 is a novel potent inhibitor of β-catenin-responsive transcription (CRT), with IC50 of 40.3 nM against Wnt responsive STF16 luciferase.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-15698A
CAS No.: 1883545-60-5
Purity:  99.92%
Target:  

PKD Pim Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

CRT0066101 dihydrochloride is a potent and orally active PKD inhibitor with IC50 values of 1 nM, 2.5 nM and 2 nM for PKD1, PKD2, and PKD3, respectively . CRT0066101 dihydrochloride is also a potent PIM2 inhibitor with an IC50 of ~135.7 nM. CRT0066101 dihydrochloride exhibits anti-inflammatory activity in mice LPS (HY-D1056)-induced lung injury models, and has anticancer effects .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-15698
CAS No.: 956123-34-5
Purity:  99.66%
Target:  

PKD Pim Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

CRT0066101 is a potent and orally active PKD inhibitor with IC50 values of 1 nM, 2.5 nM and 2 nM for PKD1, PKD2, and PKD3, respectively . CRT0066101 is also a potent PIM2 inhibitor with an IC50 of ~135.7 nM. CRT0066101 exhibits anti-inflammatory activity in mice LPS (HY-D1056)-induced lung injury models, and has anticancer effects .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-15698B
CAS No.: 1781742-22-0
Target:  

PKD Pim Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

CRT0066101 trihydrochloride is the trihydrochloride salt form of CRT0066101 (HY-15698). CRT0066101 trihydrochloride is an orally active PKD inhibitor with IC50 values of 1 nM, 2.5 nM and 2 nM for PKD1, PKD2, and PKD3, respectively. CRT0066101 trihydrochloride is also an inhibitor for PIM2 with an IC50 of ~135.7 nM. CRT0066101 trihydrochloride exhibits anti-inflammatory activity in mice LPS (HY-D1056)-induced lung injury models, and has anticancer effects .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-W014622
CAS No.: 6960-45-8
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

CRT0044876 is a potent and selective apurinic/apyrimidinic endonuclease 1 (APE1) inhibitor (IC50=~3 μM). CRT0044876 inhibits the AP endonuclease, 3′-phosphodiesterase and 3′-phosphatase activities of APE1, and is a specific inhibitor of the exonuclease III family of enzymes to which APE1 belongs. CRT0044876 potentiates the cytotoxicity of several DNA base-targeting compounds .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P84229
Synonyms: RO; CRT; SSA; cC1qR; HEL-S-99n

Host:  

Mouse

Application:  

WB, IHC-P, FC, ELISA

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-18713
CAS No.: 1438881-19-6
Target:  

PKC ROCK

CRT0066854 is a potent and selective atypical PKC isoenzymes inhibitor. CRT0066854 is against full-length (FL) PKCι, PKCζ, and ROCK-II kinases with IC50 values of 132 nM, 639 nM, and 620 nM, respectively .
loading...
    loading...
Cat. No.: HY-P11303
CAS No.: 161147-59-7
Target:  

CD74 MHC

Research Areas:  

Neurological Disease Cancer

PADRE peptide is a pan-HLA-DR binding epitope and immunostimulant. PADRE peptide binds to the peptide-binding groove of MHC class II molecules for presentation to CD4 + T cells, thereby effectively stimulating specific immune responses. PADRE peptide not only enhances anti-tumor immune responses, inhibits tumor growth and prolongs survival; it also significantly increases the frequency of E7-specific CD8 + T cells and improves therapeutic efficacy against TC-1 tumors when used in combination with E7 peptide-based vaccines and poly (I:C). The intensity of the immune response induced by PADRE peptide is lower than that of the Ii-PADRE DNA vaccine, and it fails to enhance the immune effect of CRT-E7 DNA. PADRE peptide is widely applicable to research on related tumors such as melanoma, glioblastoma and cervical cancer .
loading...
    loading...
Cat. No.: HY-120797
CAS No.: 1979939-16-6
Purity:  98.81%
Synonyms: IOA-289
Target:  

LPL Receptor

Research Areas:  

Cancer

CRT0273750 is an autotaxin (ATX) inhibitor and modulates LPA levels in plasm (IC50 = 0.014 μM). CRT0273750 can be used in ATX/LPA-dependent models of cancer .
loading...
    loading...
Cat. No.: HY-124686
CAS No.: 859218-37-4
ER-464195-01 is an orally active calreticulin (CRT) and integrin α subunits (ITGAs) binding inhibitor. ER-464195-01 inhibits leukocyte infiltration and subsequent inflammatory cascade reactions by dissociating the binding between CRT and ITGA. ER-464195-01 down-regulates the expression of pro-inflammatory genes (such as TNF-α, IL-1β, IL-6, IL-17f) induced by DSS (HY-116282C), and inhibit the phosphorylation of STAT3 and the production of serum amyloid A (SAA). ER-464195-01 can be used for the study of inflammatory bowel disease (IBD) .
loading...
    loading...
Cat. No.: HY-18713A
CAS No.: 2250019-91-9
Target:  

PKC ROCK

Research Areas:  

Neurological Disease

CRT0066854 hydrochloride is a potent and selective atypical PKCs inhibitor. CRT0066854 is against full-length (FL) PKCι, PKCζ, and ROCK-II kinases with IC50 values of 132 nM, 639 nM, and 620 nM, respectively .
loading...
    loading...
Cat. No.: HY-P5533
CAS No.: 2414254-70-7
Research Areas:  

Cancer

CRT, an iron peptide mimic, can bind to apo-transferrin (apo-Tf). CRT can be used to modify nanoparticles, and enhances drug delivery efficiency .
loading...
    loading...
Cat. No.: HY-112547
CAS No.: 1034297-58-9
Synonyms: CRT0066051
Target:  

PKD

Research Areas:  

Others

CRT5, a pyrazine benzamide, is a potent and selective inhibitor for all three isoforms of PKD in endothelial cells treated with VEGF (IC50s = 1, 2, and 1.5 nM for PKD1, PKD2, and PKD3, respectively). CRT5 decreases VEGF-induced endothelial migration, proliferation and tubulogenesis .
loading...
    loading...
Cat. No.: HY-119383
CAS No.: 18623-44-4
Purity:  ≥99.0%
Target:  

Wnt β-catenin

Research Areas:  

Cancer

iCRT-5 is a β-catenin-regulated transcription (CRT) inhibitor. iCRT-5 can block Wnt/β-catenin reporter activity and down regulate β-catenin expression. iCRT-5 can be used for the research of multiple myeloma .
loading...
    loading...
Cat. No.: HY-120025
CAS No.: 1661845-86-8
Purity:  99.91%
Target:  

LIM Kinase (LIMK)

Research Areas:  

Cancer

CRT0105950 is a potent LIMK inhibitor, with IC50s of 0.3 nM and 1 nM for LIMK1 and LIMK2 respectively. CRT0105950 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-RS13319
Research Areas:  

Others

SLC6A8 Human Pre-designed siRNA Set A contains three designed siRNAs for SLC6A8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-123345
CAS No.: 1661846-05-4
Target:  

LIM Kinase (LIMK)

Research Areas:  

Cancer

CRT 0105446 (compound 22d) is a LIMK1 inhibitor, with an IC50 of 8 nM .
loading...
    loading...
Cat. No.: HY-175493
Target:  

Parasite

Research Areas:  

Infection

CRT-IN-1 (compound 6x) is a potent chloroquine resistance transporter (CRT) inhibitor with an IC50 of 0.33 μM. CRT-IN-1 has activity .
loading...
    loading...
Cat. No.: HY-153917
Purity:  99.64%
Target:  

Phosphatase

Research Areas:  

Metabolic Disease Cancer

CRT0063465 is a Ligand of HumanPGK1andStress Sensor DJ1, with theKdof 24 μM ofPGK1. CRT0063465 modulates the shelterin complex composition and telomere Length .
loading...
    loading...
Cat. No.: HY-P11413
CAS No.: 139446-70-1
PAI-1 is a serine protease inhibitor (SERPIN). PAI-1 binds to and irreversibly inhibits uPA, tPA and furin; it also interacts with vitronectin, α1-acid glycoprotein, CRT, TLR4, proteasome α-3 subunit, uPAR, LRP1, Integrin αvβ3 and thrombin. PAI-1 regulates fibrinolysis, extracellular matrix turnover, cell migration, angiogenesis, inflammatory response and tissue remodeling; it mediates epithelial-mesenchymal transition (EMT)/endothelial-mesenchymal transition (EndMT), apoptosis and thrombus stabilization. PAI-1 can be used in research related to sepsis, acute lung injury, cardiovascular diseases, tissue fibrosis, diabetic nephropathy, obstructive nephropathy and non-insulin-dependent diabetes mellitus .
loading...
    loading...